Trial Profile
A Clinical Study to Investigate the Pharmacokinetics/Pharmacodynamics and Tolerability of DA-1229(Evogliptin) Tablet in Renal Impaired Patients
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Nov 2017
Price :
$35
*
At a glance
- Drugs Evogliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Dong-A ST
- 26 Aug 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 15 Aug 2014 New trial record